Barry Ticho sold $308K of Stoke Therapeutics (STOK)

Executed Mar 17, disclosed Mar 19, 2 days later.

Value, as filed

$308K

9,677 sh across 2 lots

Executed

Mar 17

the trade date, as filed

Disclosed

Mar 19

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Barry Ticho CHIEF MEDICAL OFFICER profile →

Barry Ticho (CHIEF MEDICAL OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $308K of STOK (9,677 sh across 2 lots, as filed), executed Mar 17.

The name

STOK

Stoke Therapeutics, Inc. STOK · Healthcare · 33 filings in 24 months ticker →

Healthcare · Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Barry Ticho in STOK

STOKSALE Stoke Therapeutics, Inc. $185K
6,995 sh × $26.38
Exec Nov 2
Filed Nov 4 · 4:05 PM ET STOKSALE Stoke Therapeutics, Inc. $120K
3,945 sh × $30.51
Exec Sep 1
Filed Sep 3 · 4:17 PM ET STOKSALE Stoke Therapeutics, Inc. $145K
4,525 sh × $32.01
Exec Aug 18
Filed Aug 18 · 8:29 PM ET STOKSALE Stoke Therapeutics, Inc. $171K
5,907 sh × $28.95
Exec Aug 3
Filed Aug 5 · 4:17 PM ET STOKSALE Stoke Therapeutics, Inc. $219K
6,728 sh × $32.62
Exec Jul 1
Filed Jul 6 · 4:10 PM ET STOKSALE Stoke Therapeutics, Inc. $126K
5,343 sh × $23.64
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $109K
5,501 sh × $19.87
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $229K
22,790 sh × $10.03
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET